欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0339/001
药品名称Galantamine 4mg/ml Oral Solution
活性成分
    • galantamine 4.0 mg/ml
剂型Oral solution
上市许可持有人Syri Pharma Limited t/a Thame Laboratories Floor 0, 1 WML, 1 Windmill Lane, Dublin , D02 F206, Ireland. Syri Limited t/a Thame Laboratories Unit 4, Bradfi eld Road, Rui slip, Middlesex HA4 0NU
参考成员国 - 产品名称Malta (MT)
Galantamine Oral Solution 4mg/ml
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
许可日期2016/09/19
最近更新日期2022/12/20
药物ATC编码
    • N06DA04 galantamine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase